Abstract

Protein aggregation is the underlying cause of many diseases, and also limits the usefulness of many natural and engineered proteins in biotechnology. Better mechanistic understanding and characterization of aggregation-prone states is needed to guide protein engineering, formulation, and drug-targeting strategies that prevent aggregation. While several final aggregated states—notably amyloids—have been characterized structurally, very little is known about the native structural conformers that initiate aggregation. We used a novel combination of small-angle x-ray scattering (SAXS), atomistic molecular dynamic simulations, single-molecule Förster resonance energy transfer, and aggregation-prone region predictions, to characterize structural changes in a native humanized Fab A33 antibody fragment, that correlated with the experimental aggregation kinetics. SAXS revealed increases in the native state radius of gyration, Rg, of 2.2% to 4.1%, at pH 5.5 and below, concomitant with accelerated aggregation. In a cutting-edge approach, we fitted the SAXS data to full MD simulations from the same conditions and located the conformational changes in the native state to the constant domain of the light chain (CL). This CL displacement was independently confirmed using single-molecule Förster resonance energy transfer measurements with two dual-labeled Fabs. These conformational changes were also found to increase the solvent exposure of a predicted APR, suggesting a likely mechanism through which they promote aggregation. Our findings provide a means by which aggregation-prone conformational states can be readily determined experimentally, and thus potentially used to guide protein engineering, or ligand binding strategies, with the aim of stabilizing the protein against aggregation.

Highlights

  • Elucidating how proteins misfold or partially unfold before they aggregate remains a key challenge with significant impact in medicine and biotechnology [1]

  • These yielded the radius of gyration Rg and the intensity at zero Q I(0), the latter being proportional to the molecular weight

  • When the intensities were fitted to larger Q values, linear non-aggregated Guinier plots with satisfactory Q.Rg ranges were identified that were distinct from the Guinier fits for aggregated fragment antigen-binding (Fab) A33

Read more

Summary

Introduction

Elucidating how proteins misfold or partially unfold before they aggregate remains a key challenge with significant impact in medicine and biotechnology [1]. Many natural or newly engineered proteins suffer from aggregation during development, which is highly undesirable as they may elicit adverse immune responses in patients, and so must be avoided [4,5]. Aggregates are observed at all stages of drug product development, including expression, purification, shipping and storage [7,8]. Protein engineering and formulation are two potential avenues to minimize protein aggregation. In order to improve success, the molecular mechanisms that lead to aggregation need to be understood first, so that informed rational decisions can be made. Understanding the mechanisms by which soluble protein molecules misfold and aggregate is of fundamental and biomedical importance

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call